Clinical and Laboratory Characteristics of SARS-CoV2-infected Paediatric Patients in Jordan: Serial RT-PCR Testing Until Discharge
Overview
Public Health
Tropical Medicine
Affiliations
Background: Data on COVID-19 in children are limited. This study aimed to identify the clinical characteristics, laboratory results and longitudinal RT-PCR- testing pattern in children infected with theSARS-CoV2 virus and admitted to a hospital in Jordan.
Methods: The study is a retrospective chart review of patients admitted between 16 March and 23 April 2020. All infected children in Jordan were hospitalised. Serial RT-PCR testing was undertaken 7 days after the first test and then on alternate days until discharge. The association between patient symptoms and laboratory results and whether there was a statistically significant median difference in the number of days until negative RT-PCR results between patients was studied.
Results: Sixty-one patients with positive SARS-CoV2 swabs were admitted, 34 (55.7%) of whom were symptomatic. The most common symptom was nasal congestion (21/61, 34.3%), followed by generalised malaise and headache (12/6, 19.7%). A rash was detected in 5/61 (8.2%) of them. Fifty-five patients (90.1%) underwent investigations: 4 (7.4%) of them had lymphopenia, 4 (7.4%) had eosinopenia, 8 (14.5%) had eosinophilia, and platelets were elevated in 5 (9.1%) children. CRP was measured in 33/61 (54.1%) patients and all were normal. ESR levels were available for 11/61 (18%) patients and were elevated in 5 (45.5%). There was a statistically significant association between laboratory results and symptom expression ( = 0.011). The longest time until the first negative RT-PCR result was 39 days.
Conclusion: All children admitted who tested positive for SARS-CoV2 had mild symptoms and five had cutaneous manifestations. RT-PCR may remain positive for over one month.
Shalabi M, Ghanem S, Al-Ammouri I, Daher A, Al-Zayadneh E, Alsmadi A Glob Epidemiol. 2025; 9:100185.
PMID: 39911527 PMC: 11795814. DOI: 10.1016/j.gloepi.2025.100185.
Zheng Y, Zhang H, Weng Z, He H, Chen W, Zheng M Biomed Rep. 2024; 20(2):29.
PMID: 38259584 PMC: 10801348. DOI: 10.3892/br.2023.1717.
Prognosis of COVID-19 in the middle eastern population, knowns and unknowns.
Dandachi I, Aljabr W Front Microbiol. 2022; 13:974205.
PMID: 36118201 PMC: 9471247. DOI: 10.3389/fmicb.2022.974205.
COVID-19 Pediatric Dermatology.
Neale H, Hawryluk E Dermatol Clin. 2021; 39(4):505-519.
PMID: 34556241 PMC: 8165089. DOI: 10.1016/j.det.2021.05.012.
Clinical Patterns and Morphology of COVID-19 Dermatology.
Agnihothri R, Fox L Dermatol Clin. 2021; 39(4):487-503.
PMID: 34556240 PMC: 8165088. DOI: 10.1016/j.det.2021.05.006.